Prevention of cancer by prophylactic human papillomavirus vaccines
- 1 April 2011
- journal article
- review article
- Published by Elsevier in Current Opinion in Immunology
- Vol. 23 (2) , 244-251
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- In Vivo Mechanisms of Vaccine-Induced Protection against HPV InfectionCell Host & Microbe, 2010
- Characterization of the HPV-specific memory B cell and systemic antibody responses in women receiving an unadjuvanted HPV16 L1 VLP vaccineVaccine, 2010
- Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infectionVaccine, 2010
- Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendmentsVirology, 2010
- Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus VaccinesJNCI: Journal of the National Cancer Institute, 2009
- Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinomaVaccine, 2009
- Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infectionImmunology & Cell Biology, 2009
- Mechanisms of Human Papillomavirus Type 16 Neutralization by L2 Cross-Neutralizing and L1 Type-Specific AntibodiesJournal of Virology, 2008
- A Protective and Broadly Cross-Neutralizing Epitope of Human Papillomavirus L2Journal of Virology, 2007
- Papillomaviruses and cancer: from basic studies to clinical applicationNature Reviews Cancer, 2002